ERAS CIK: 1761918

Erasca, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−79.6
FY22:
−103
FY23:
−101
FY24:
−109
FY25:
−95.5
Change from FY21 to FY25
millions USD
FY21:
−64.6
FY22:
−71.1
FY23:
−91.2
FY24:
−157
FY25:
100
Change from FY21 to FY25
millions USD
FY21:
439
FY22:
98.1
FY23:
1.30
FY24:
241
FY25:
1.10
millions USD
FY21:
295
FY22:
−76.3
FY23:
−191
FY24:
−25.3
FY25:
6.07
(positive)
Change from FY21 to FY25
millions USD
FY21:
−90.8
FY22:
−118
FY23:
−103
FY24:
−109
FY25:
−95.6

All amounts in millions USD Data source:SEC EDGAR